Addressing the Needs of HIV-Positive Adolescents

There are many children who contracted HIV as infants, through mother-to-child transmission, growing into adolescents. As sexuality develops in this phase of life, so too does the risk of contracting HIV. This is a uniquely underreported and high-risk group. At one EGPAF-supported site in Kenya, staff are doing all they can to support their local teens. Keep reading

Publication Spotlight: How Can We End Pediatric HIV?

In the March 2015 issue of The Lancet HIV, EGPAF’s Senior Director of Technical Leadership, Innovations, and Sustainability Francesca Celletti, M.D. is the lead author on a new commentary outlining the need for HIV treatment and elimination targets for child living with HIV. Keep reading

Developing and Delivering Appropriate HIV Medicines for Children

Today (Feb. 24) the Medicines Patent Pool (MPP) announced a new licensing agreement with pharmaceutical company Merck & Co. that will allow generic manufacturers to produce low-cost pediatric versions of Merck's HIV medication, raltegravir. Read a blog from MPP's Executive Director Greg Perry on the importance of these agreements. Keep reading

Swaziland Adolescents Work Toward an HIV-free Generation

During most of his teen years, Mbongeni Dlamini wondered if he would ever ask a girl to go out with him. His normal adolescent fears were compounded by the fact that he is HIV-positive. Today, through his involvement with a psychosocial support group, Mbongen has the confidence to envision a girlfriend — and eventually a wife and family. Keep reading